Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer Journal Article

  

Authors:	Tavorath, R.; Pfister, D. G.
Article Title:	Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer
Abstract:	The identification and development of new agents and innovative treatment approaches remain a priority. The prognosis for patients with recurrent or metastatic head and neck cancer remains poor; thus participation in trials of promising investigational agents is an important option for these individuals. For patients with locally advanced tumors, combined modality treatment is undergoing rapid evolution. The optimal combination and sequence of therapies have yet to be determined. However, available data support an increasing role for chemotherapy especially as part of strategies to preserve organ function and treat unresectable disease.
Keywords:	review; cancer recurrence; cisplatin; fluorouracil; multimodality cancer therapy; metastasis; vinblastine; head and neck cancer; lonidamine; human; priority journal
Journal Title:	Current Opinion in Oncology
Volume:	7
Issue:	3
ISSN:	1040-8746
Publisher:	Lippincott Williams & Wilkins
Date Published:	1995-05-01
Start Page:	242
End Page:	247
Language:	English
DOI:	10.1097/00001622-199505000-00009
PUBMED:	7654826
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028919068&doi=10.1097%2f00001622-199505000-00009&partnerID=40&md5=ac9953f7e447dc20549601349ea4df51
Notes:	Review -- Export Date: 28 August 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/132284